BioCentury
ARTICLE | Clinical News

Narcan naloxone regulatory update

October 19, 2015 7:00 AM UTC

FDA accepted and granted Priority Review to an NDA from Adapt for Narcan naloxone Nasal Spray to treat opioid overdose. The PDUFA date is in early 2016. Adapt has worldwide rights to develop and comm...